Skip to content

Clinical Study of Moisture Sensor Dressing Used for Exuding Wounds

Post Market Clinical Follow-up (PMCF) Study for DryMax Sensor

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04890769
Enrollment
4
Registered
2021-05-18
Start date
2021-05-21
Completion date
2022-02-22
Last updated
2022-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exuding Wounds, Ulcer, Leg, Wound

Brief summary

Observational prospective study of the clinical use of a wound dressing with a moisture sensor for use on exuding wounds.

Detailed description

The PMCF study will be performed as a prospective and open study of a wound dressing with a moisture sensor on exuding wounds. Using DryMax Sensor and the display indication - advisory only - might influence the clinician's workflow and the patient's engagement in their care. The PMCF study aims to study the use of the sensor in the clinical procedure of dressing changes in one or more healthcare settings. To study how the new product is received, and how it is used in the workflow, related to its clinical performance. Furthermore, the aim is to gather safety-related clinical data for common harms within exudate management.

Interventions

DEVICEMoisture sensor wound dressing

Clinical procedure for change of wound dressing

Sponsors

Primary Health Care Center, Department of Health Medicine and Caring Sciences, Linköping University, Linköping, Sweden
CollaboratorUNKNOWN
Fredrik Iredahl
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* male or female, ≥18 years * presence of an exuding wound, according to the clinician's assessment * the wound is deemed suitable for treatment with DryMax Sensor * an appropriate dressing size is available to be used according to the size of the wound * the participant has given a written informed consent to participate in the study.

Exclusion criteria

* known pregnancy at the inclusion visit * known or suspected hypersensitivity to the DryMax Sensor or its components * mental inability, reluctance or language difficulties that cause difficulties in understanding the meaning of participating in the study * ongoing treatment with systemic antibiotics * illness or treatment of an indication other than the wound and which, according to the study personnel, can affect the wound treatment, the study, and/or the dressing.

Design outcomes

Primary

MeasureTime frameDescription
Questionnaire regarding workflow of the clinical procedure for dressing changeEnrollment to study completion (4 weeks)Yes/no questions and questions with multiple choices
Questionnaire regarding the satisfaction using the deviceThrough study completion, up to 4 weeksScale 1-5 where 1= low, 5 = good
Registration of device deficienciesEnrollment to study completion (4 weeks)Type of device deficiency

Secondary

MeasureTime frameDescription
Questionnaire regarding leakage, strike-through, exudate viscosityEnrollment to study completion (4 weeks)Yes/no questions and questions with multiple choices
Number of days between visitsEnrollment to study completion (4 weeks)Dressing change frequency
Measurement of wound size with a rulerEnrollment to study completion (4 weeks)Wound size progression
Questionnaire regarding wound statusEnrollment to study completion (4 weeks)Questions with multiple choices
Weight of dressing after use using a balanceEnrollment to study completion (4 weeks)Utilisation of dressings capacity
Registration of time for display activationEnrollment to study completion (4 weeks)Time for display activation - hours since application \[h\]

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026